China Tech 🇨🇳 AI NewsInsilico Medicine has signed a global licensing deal worth up to 2.75 billion USD with Eli Lilly for an AI-discovered oral GLP-1 drug. The Hong Kong-listed AI drug discovery company received 115 million USD upfront and reported 2025 revenue of 56.2 million USD, with its drug discovery segment growing 693.6% year-over-year. https://pandaily.com/insilico-medicine-signs-2-75-b-deal-with-eli-lilly #China #Tech #AI #Insilico
tech news ᳇ eicker.news#EliLilly and #Insilico Medicine have signed a $2.75 billion deal to bring #AIdeveloped #drugs to the global market. The agreement includes upfront payments, milestone payments, and royalties, and builds on their existing collaboration. https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html?eicker.news #tech #media #news
gaby_waldIl y a des projets auxquels j'ai participé et / ou donné mon avis professionnel qui ne décollent pas, et dont la dénomination se diffuse dans le "domaine public" : les clients potentiels ont des attentes non-dites...
#BioInformatique #InVivo #InVitro #InSilico #JumeauNumérique
Fabrizio MusacchioEfforts to reduce animal experiments are important and should be pursued. But despite progress in #AI, #organoids, and #InSilico models, I’m not convinced we’re there yet — especially in #neuroscience, where #complexity and systemic #context matter. However, I do think we should stay committed and aim for reduction by all available means. I recently came across this article, which gives a good overview of the current state of the field:
José A. Callejón#Insilico #Medicine crea el primer medicamento real mediante inteligencia artificial cuya capacidad para #curar una enfermedad pulmonar mortal en humanos ya ha sido probada.
El fundador de la empresa afirma que la #IA podrá indicar a los investigadores nuevos tratamientos en los que nunca habrían pensado por sí solos y acelerar las fases iniciales del #descubrimiento de nuevos tratamientos, ofreciendo sugerencias sobre qué objetivos deben alcanzarse con los #fármacos.
Quantum ObserverQuantum Computing Can Help Unlock Understanding of Aging And Disease https://thequantuminsider.com/?p=2360517 #Research #aging #disease #Foxconn #Insilico #Insilico_Medicine #longevity #Quantum_Life #university_of_toronto #quantumdaily Insider Brief Researchers demonstrate how quantum computing can be integrated into the study of living organisms. The team believes it could provide greater insight into biological processes like aging and disease. Insilico, University of Toronto’s Acceleration C
JamesLundblad#InSilico #Brain #SimulationNeuroscience
https://www.youtube.com/watch?v=IdfdOZsRpQE&ab_channel=YouTubeMovies
https://www.youtube.com/watch?v=IdfdOZsRpQE&ab_channel=YouTubeMovies
In Silico
Marlene Mengoni#introduction Associate Prof in #medical #computational engineering at University of Leeds, interest in #musculoskeletal #biomechanics and using combined #invitro and #insilico methods to understand how everyone's joint is different, and how to use that knowledge in developing and testing repair devices.
Arli A P@academicchatter @academicsunite Dear all. Anybody working with the #computational side of #environmental #biotechnology ? We try to devise #bioinformatics approach to investigates human coagulation factor II that is responsible for blod clotting as a possible method for water treatment against gram negative #bacteria (GNB). We tap in into the possibilities whether factor II could hydrolyse GNB in this #insilico implementations. You can check the paper in here: https://zenodo.org/record/5219013#.Y3Lo7uxBxQJ 🙂
In silico computation of coagulation factor II: a potential water treatment agent against gram negative bacteria
Water as one of the main sources of life, holds an important aspect to public health and safety. Up until now there have been many concerns about water pollution especially in developing countries. Heavy polluted water that is not treated well could cause many concerning diseases that can lead to deaths. Contaminants that came from chemical, physical, and biological compounds are commonly found in the water sources. Gram negative bacteria (GNB) has been shown to develop multiple drugs and antibiotics resistant, making the infection more fatal. This has become a major concern on public health especially in water treatment as it becomes more challenging. Our study investigates human coagulation factor II that is responsible for blood clotting as a possible method for water treatment against GNB. By investigating the coagulation protein interaction with several bacterial lipopolysaccharides proteins and calculating the binding affinity of the interaction, the results show factor II has a lower binding affinity compared to previously studied factor VII. This shows possibilities of factor II to hydrolyse several gram-negative bacteria to act as a potential treatment against these GNBs.